LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.71 | 17.25 | 273 | 6184 | 0.0441 | 0.3846 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.71 | 17.25 | 11260 | 6184 | 1.8208 | 1.1463 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.71 | 17.25 | 43 | 6184 | 0.0070 | 0.1136 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.71 | 17.25 | 12126 | 6184 | 1.9608 | 1.1652 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 94.68 | 17.25 | 178 | 6239 | 0.0285 | 0.3160 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 94.68 | 17.25 | 11457 | 6239 | 1.8363 | 1.1483 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 94.68 | 17.25 | 36 | 6239 | 0.0058 | 0.0904 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 94.68 | 17.25 | 12536 | 6239 | 2.0092 | 1.1711 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 3.06 | 17.25 | 9 | 143 | 0.0628 | -0.1919 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 3.06 | 17.25 | 288 | 143 | 2.0110 | 1.5142 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 3.06 | 17.25 | 519 | 143 | 3.6239 | 2.0491 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 5.03 | 17.25 | 16 | 273 | 0.0585 | -0.0187 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 5.03 | 17.25 | 446 | 273 | 1.6316 | 1.2614 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 5.03 | 17.25 | 732 | 273 | 2.6778 | 1.5607 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 7.01 | 17.25 | 22 | 389 | 0.0565 | 0.0556 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 7.01 | 17.25 | 665 | 389 | 1.7073 | 1.2526 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 7.01 | 17.25 | 924 | 389 | 2.3723 | 1.4236 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 8.98 | 17.25 | 19 | 445 | 0.0427 | 0.0208 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 8.98 | 17.25 | 801 | 445 | 1.7997 | 1.2670 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 8.98 | 17.25 | 2 | 445 | 0.0045 | -0.3684 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 8.98 | 17.25 | 968 | 445 | 2.1749 | 1.3604 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 10.95 | 17.25 | 19 | 471 | 0.0403 | 0.0204 | MN20160310_N02 | E22 |